Literature DB >> 9542731

The neurochemical markers in cerebrospinal fluid to differentiate between aseptic and tuberculous meningitis.

G A Qureshi1, S M Baig, I Bednar, A Halawa, S H Parvez.   

Abstract

In this study, the use of neurochemical markers in patients with aseptic and tuberculous meningitis has been investigated. The cerebrospinal fluid levels of amino acids, nitrite (a metabolite of nitric oxide), vitamin B12 and homocysteine were quantitated in both groups of patients. Among the amino acids, aspartic acid and glutamic acid both excitatory amino acid, GABA, glycine and tryptophan were all significantly increased in both patient groups whereas decreased level of taurine and increased level of phenylalanine were only found in patients with tuberculous meningitis. The levels of nitrite and its precursor arginine were significantly higher in patients with tuberculous meningitis whereas unchanged levels were found in patients with aseptic meningitis. A significantly increased homocysteine level and a decreased level of vitamin B12 were found only in patients with tuberculous meningitis whereas unchanged levels were found in patients with aseptic meningitis. This indicates that patients with tuberculous meningitis are particularly prone to vitamin B12 deficiency resulting into increased level of HC, and involvement of free radical showing the importance of these biological markers for promoting the possibility for the design of therapeutic approach.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9542731     DOI: 10.1016/s0197-0186(97)00061-2

Source DB:  PubMed          Journal:  Neurochem Int        ISSN: 0197-0186            Impact factor:   3.921


  2 in total

1.  A putative role for homocysteine in the pathophysiology of acute bacterial meningitis in children.

Authors:  Roney Santos Coimbra; Bruno Frederico Aguilar Calegare; Talitah Michel Sanchez Candiani; Vânia D'Almeida
Journal:  BMC Clin Pathol       Date:  2014-11-22

2.  Cerebrospinal Fluid Amino Acid Profiling of Pediatric Cases with Tuberculous Meningitis.

Authors:  Shayne Mason; Carolus J Reinecke; Regan Solomons
Journal:  Front Neurosci       Date:  2017-09-26       Impact factor: 4.677

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.